뉴스벤징가
Viridian Secures First FDA Approval, Sets Up Challenge To Amgen's Tepezza For Thyroid Eye Disease
· 발표
기사 요약
FDA approves Viridian Therapeutics' Lumvoa for thyroid eye disease. Immediate commercial launch scheduled with full patient support.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…